129 filings
8-K
MREO
Mereo Biopharma Group Plc
11 Jun 24
Regulation FD Disclosure
9:15pm
8-K
MREO
Mereo Biopharma Group Plc
23 May 24
Submission of Matters to a Vote of Security Holders
4:16pm
8-K
MREO
Mereo Biopharma Group Plc
15 May 24
Mereo BioPharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
4:06pm
8-K
MREO
Mereo Biopharma Group Plc
15 Apr 24
Entry into a Material Definitive Agreement
7:30am
8-K
MREO
Mereo Biopharma Group Plc
27 Mar 24
Mereo BioPharma Reports Full Year 2023 Financial Results and Provides Corporate Update
4:08pm
8-K
49ekhy536jftygs6
8 Jan 24
Mereo BioPharma Provides Update on Pipeline Progress and Corporate Developments
7:08am
6-K
omlzd5nk qx
18 Dec 23
Current report (foreign)
4:10pm
6-K
jrjujpgfupxes
29 Nov 23
Current report (foreign)
4:15pm
6-K
vh7yuts
16 Nov 23
Current report (foreign)
7:01am
6-K
70uvuaj n9vgmzgv7it
23 Oct 23
Mereo BioPharma Reports on Recent Program Developments and Provides Financial Update
4:08pm
6-K
agnnp
17 Oct 23
Current report (foreign)
7:01am
6-K
2xdxz
20 Sep 23
Current report (foreign)
4:03pm
6-K
6imjyh5bx8v8 7s37gus
7 Sep 23
Current report (foreign)
7:37am
6-K
uw6dy9kdm5yzevi8nv4l
6 Jul 23
Ultragenyx Announces First Patients Dosed in Phase 3 Program
8:05am
6-K
z59uk4euv2qh zo
30 Jun 23
Current report (foreign)
4:05pm
6-K
mbrr4m q9k
7 Jun 23
Current report (foreign)
8:41am
6-K
3o4 w5h5rb1uogpoy
5 Jun 23
Ultragenyx and Mereo BioPharma Announce Positive Data from the Ongoing Phase 2/3 Orbit
4:37pm
6-K
dycol vyblo9m
22 May 23
Current report (foreign)
4:15pm
6-K
74q1y 47bjh1jy
8 May 23
Current report (foreign)
4:07pm
6-K
55aw951urd b2
5 May 23
Mereo BioPharma Announces Listing Transfer to Nasdaq Capital Market
5:06pm